US Stock MarketDetailed Quotes

SPRB Spruce Biosciences

Watchlist

0.750
-0.020-2.58%

Close May 17 16:00 ET

0.750
+0.000+0.01%

Post 18:06 ET

30.87MMarket Cap-669P/E (TTM)

Spruce Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-26.87%-14.96M

20.17%-33.28M

4.51%-11.21M

-43.03%-12.27M

120.89%1.99M

0.30%-11.79M

-16.18%-41.68M

-19.79%-11.74M

-12.91%-8.58M

1.58%-9.54M

Net income from continuing operations

9.12%-11.63M

-3.77%-47.92M

10.71%-9.95M

-8.36%-12.35M

-8.01%-12.82M

-8.75%-12.79M

-9.19%-46.18M

-21.34%-11.14M

0.40%-11.4M

-0.84%-11.87M

Operating gains losses

----

-94.87%2K

--0

--2K

--39K

----

Depreciation and amortization

-21.05%15K

-5.41%70K

-33.33%16K

-26.09%17K

200.00%18K

-9.52%19K

8.82%74K

20.00%24K

27.78%23K

-64.71%6K

Other non cash items

148.00%60K

158.23%230K

109.15%59K

-32.14%57K

184.52%239K

-252.44%-125K

-226.20%-395K

-906.25%-645K

7.69%84K

Change In working capital

-11,144.44%-4.97M

814.84%10.36M

-245.21%-2.49M

-150.36%-973K

971.83%13.77M

103.30%45K

-42.10%1.13M

54.16%-721K

-27.53%1.93M

32.20%1.29M

-Change in receivables

--0

----

---15M

----

-Change in prepaid assets

-128.77%-191K

-222.64%-2.64M

-274.19%-3.58M

-44.47%236K

-91.62%45K

180.78%664K

-296.87%-817K

27.66%-957K

-23.01%425K

-40.00%537K

-Change in payables and accrued expense

-327.42%-2.8M

272.65%8.16M

1,139.57%4.04M

25.16%1.95M

16.22%946K

343.85%1.23M

46.10%2.19M

228.35%326K

-20.80%1.55M

740.94%814K

-Change in other current assets

-52.87%74K

6.67%96K

-216.67%-14K

-168.63%-35K

---12K

481.48%157K

-54.31%90K

-81.82%12K

-49.00%51K

--0

-Change in other current liabilities

-34.15%-55K

46.83%-176K

52.94%-48K

53.06%-46K

37.88%-41K

36.92%-41K

-112.18%-331K

-64.52%-102K

-63.33%-98K

-15.79%-66K

-Change in other working capital

-115.37%-2M

--4.91M

---2.89M

---3.07M

---2.17M

--13.04M

----

Cash from discontinued investing activities

Operating cash flow

-26.87%-14.96M

20.17%-33.28M

4.51%-11.21M

-43.03%-12.27M

120.89%1.99M

0.30%-11.79M

-16.18%-41.68M

-19.79%-11.74M

-12.91%-8.58M

1.58%-9.54M

Investing cash flow

Cash flow from continuing investing activities

135.43%55.78M

-36.17%9.3M

182.83%13.99M

-34.34%22M

239.95%10.48M

129.93%23.69M

343.51%14.57M

-36.95%-16.89M

155.08%33.51M

Net PPE purchase and sale

----

12.50%-7K

--0

-250.00%-7K

----

91.40%-8K

--0

96.92%-2K

----

Net investment purchase and sale

--0

135.38%55.78M

-36.17%9.3M

182.88%14M

-34.35%22M

239.95%10.48M

129.97%23.7M

343.75%14.57M

-37.66%-16.89M

155.09%33.51M

Cash from discontinued investing activities

Investing cash flow

--0

135.43%55.78M

-36.17%9.3M

182.83%13.99M

-34.34%22M

239.95%10.48M

129.93%23.69M

343.51%14.57M

-36.95%-16.89M

155.08%33.51M

Financing cash flow

Cash flow from continuing financing activities

-100.45%-227K

20,490.04%49.14M

-1,633.33%-552K

-350.00%-405K

-336.36%-432K

57,519.32%50.53M

-137.48%-241K

-78.44%36K

-629.41%-90K

-156.25%-99K

Net issuance payments of debt

0.00%-405K

---1.62M

---406K

---405K

---406K

---405K

--0

Net common stock issuance

--0

--53.62M

--0

--53.62M

--0

Proceeds from stock option exercised by employees

--180K

128.21%178K

86.84%71K

--0

181.58%107K

--0

-83.12%78K

-81.55%38K

--0

-78.41%38K

Net other financing activities

99.93%-2K

-850.47%-3.03M

-10,750.00%-217K

--0

2.92%-133K

-2,880.00%-2.68M

-717.95%-319K

---2K

---90K

---137K

Cash from discontinued financing activities

Financing cash flow

-100.45%-227K

20,490.04%49.14M

-1,633.33%-552K

-350.00%-405K

-336.36%-432K

57,519.32%50.53M

-137.48%-241K

-78.44%36K

-629.41%-90K

-156.25%-99K

Net cash flow

Beginning cash position

289.67%96.37M

-42.44%24.73M

352.02%98.84M

105.62%97.52M

213.91%73.96M

-42.44%24.73M

-72.70%42.96M

-62.67%21.87M

-39.58%47.43M

-84.17%23.56M

Current changes in cash

-130.85%-15.19M

492.95%71.64M

-185.84%-2.46M

105.16%1.32M

-1.28%23.56M

353.66%49.22M

84.06%-18.23M

118.36%2.87M

-28.35%-25.56M

133.93%23.87M

End cash Position

9.78%81.19M

289.67%96.37M

352.02%98.84M

105.62%97.52M

213.91%73.96M

-42.44%24.73M

-62.67%21.87M

-39.58%47.43M

Free cash flow

-26.87%-14.96M

20.17%-33.28M

4.51%-11.21M

-43.08%-12.28M

120.88%1.99M

0.30%-11.79M

-15.90%-41.69M

-19.71%-11.74M

-11.98%-8.58M

1.55%-9.55M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-26.87%-14.96M	20.17%-33.28M	4.51%-11.21M	-43.03%-12.27M	120.89%1.99M	0.30%-11.79M	-16.18%-41.68M	-19.79%-11.74M	-12.91%-8.58M	1.58%-9.54M
Net income from continuing operations	9.12%-11.63M	-3.77%-47.92M	10.71%-9.95M	-8.36%-12.35M	-8.01%-12.82M	-8.75%-12.79M	-9.19%-46.18M	-21.34%-11.14M	0.40%-11.4M	-0.84%-11.87M
Operating gains losses	----	-94.87%2K	--0	--0	--0	--2K	--39K	----	----	----
Depreciation and amortization	-21.05%15K	-5.41%70K	-33.33%16K	-26.09%17K	200.00%18K	-9.52%19K	8.82%74K	20.00%24K	27.78%23K	-64.71%6K
Other non cash items	148.00%60K	158.23%230K	109.15%59K	-32.14%57K	184.52%239K	-252.44%-125K	-226.20%-395K	-906.25%-645K	7.69%84K	7.69%84K
Change In working capital	-11,144.44%-4.97M	814.84%10.36M	-245.21%-2.49M	-150.36%-973K	971.83%13.77M	103.30%45K	-42.10%1.13M	54.16%-721K	-27.53%1.93M	32.20%1.29M
-Change in receivables	--0	----	----	----	----	---15M	----	----	----	----
-Change in prepaid assets	-128.77%-191K	-222.64%-2.64M	-274.19%-3.58M	-44.47%236K	-91.62%45K	180.78%664K	-296.87%-817K	27.66%-957K	-23.01%425K	-40.00%537K
-Change in payables and accrued expense	-327.42%-2.8M	272.65%8.16M	1,139.57%4.04M	25.16%1.95M	16.22%946K	343.85%1.23M	46.10%2.19M	228.35%326K	-20.80%1.55M	740.94%814K
-Change in other current assets	-52.87%74K	6.67%96K	-216.67%-14K	-168.63%-35K	---12K	481.48%157K	-54.31%90K	-81.82%12K	-49.00%51K	--0
-Change in other current liabilities	-34.15%-55K	46.83%-176K	52.94%-48K	53.06%-46K	37.88%-41K	36.92%-41K	-112.18%-331K	-64.52%-102K	-63.33%-98K	-15.79%-66K
-Change in other working capital	-115.37%-2M	--4.91M	---2.89M	---3.07M	---2.17M	--13.04M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-26.87%-14.96M	20.17%-33.28M	4.51%-11.21M	-43.03%-12.27M	120.89%1.99M	0.30%-11.79M	-16.18%-41.68M	-19.79%-11.74M	-12.91%-8.58M	1.58%-9.54M
Investing cash flow
Cash flow from continuing investing activities	0	135.43%55.78M	-36.17%9.3M	182.83%13.99M	-34.34%22M	239.95%10.48M	129.93%23.69M	343.51%14.57M	-36.95%-16.89M	155.08%33.51M
Net PPE purchase and sale	----	12.50%-7K	--0	-250.00%-7K	----	----	91.40%-8K	--0	96.92%-2K	----
Net investment purchase and sale	--0	135.38%55.78M	-36.17%9.3M	182.88%14M	-34.35%22M	239.95%10.48M	129.97%23.7M	343.75%14.57M	-37.66%-16.89M	155.09%33.51M
Cash from discontinued investing activities
Investing cash flow	--0	135.43%55.78M	-36.17%9.3M	182.83%13.99M	-34.34%22M	239.95%10.48M	129.93%23.69M	343.51%14.57M	-36.95%-16.89M	155.08%33.51M
Financing cash flow
Cash flow from continuing financing activities	-100.45%-227K	20,490.04%49.14M	-1,633.33%-552K	-350.00%-405K	-336.36%-432K	57,519.32%50.53M	-137.48%-241K	-78.44%36K	-629.41%-90K	-156.25%-99K
Net issuance payments of debt	0.00%-405K	---1.62M	---406K	---405K	---406K	---405K	--0	--0	--0	--0
Net common stock issuance	--0	--53.62M	--0	--0	--0	--53.62M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	--180K	128.21%178K	86.84%71K	--0	181.58%107K	--0	-83.12%78K	-81.55%38K	--0	-78.41%38K
Net other financing activities	99.93%-2K	-850.47%-3.03M	-10,750.00%-217K	--0	2.92%-133K	-2,880.00%-2.68M	-717.95%-319K	---2K	---90K	---137K
Cash from discontinued financing activities
Financing cash flow	-100.45%-227K	20,490.04%49.14M	-1,633.33%-552K	-350.00%-405K	-336.36%-432K	57,519.32%50.53M	-137.48%-241K	-78.44%36K	-629.41%-90K	-156.25%-99K
Net cash flow
Beginning cash position	289.67%96.37M	-42.44%24.73M	352.02%98.84M	105.62%97.52M	213.91%73.96M	-42.44%24.73M	-72.70%42.96M	-62.67%21.87M	-39.58%47.43M	-84.17%23.56M
Current changes in cash	-130.85%-15.19M	492.95%71.64M	-185.84%-2.46M	105.16%1.32M	-1.28%23.56M	353.66%49.22M	84.06%-18.23M	118.36%2.87M	-28.35%-25.56M	133.93%23.87M
End cash Position	9.78%81.19M	289.67%96.37M	289.67%96.37M	352.02%98.84M	105.62%97.52M	213.91%73.96M	-42.44%24.73M	-42.44%24.73M	-62.67%21.87M	-39.58%47.43M
Free cash flow	-26.87%-14.96M	20.17%-33.28M	4.51%-11.21M	-43.08%-12.28M	120.88%1.99M	0.30%-11.79M	-15.90%-41.69M	-19.71%-11.74M	-11.98%-8.58M	1.55%-9.55M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall